Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Some supplements may help with hair loss, but there's not enough strong evidence to recommend them without doctor advice.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.